chr1-27892190-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_002946.5(RPA2):c.786C>A(p.Asp262Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002946.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPA2 | NM_002946.5 | c.786C>A | p.Asp262Glu | missense_variant | 9/9 | ENST00000373912.8 | NP_002937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPA2 | ENST00000373912.8 | c.786C>A | p.Asp262Glu | missense_variant | 9/9 | 1 | NM_002946.5 | ENSP00000363021.3 | ||
RPA2 | ENST00000313433.11 | c.1050C>A | p.Asp350Glu | missense_variant | 8/8 | 1 | ENSP00000363015.3 | |||
RPA2 | ENST00000373909.7 | c.810C>A | p.Asp270Glu | missense_variant | 9/9 | 3 | ENSP00000363017.3 | |||
RPA2 | ENST00000419958.5 | c.342C>A | p.Asp114Glu | missense_variant | 4/5 | 3 | ENSP00000413541.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460426Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726408
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.786C>A (p.D262E) alteration is located in exon 9 (coding exon 9) of the RPA2 gene. This alteration results from a C to A substitution at nucleotide position 786, causing the aspartic acid (D) at amino acid position 262 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at